In- silico Design of Novel Inhibitors for Benzimidazole Receptor against Cryptosporidium parvum

Authors

  • Isha Chandra Department of Biotechnology, Institute of Engineering & Technology, Uttar Pradesh Technical University, Lucknow, India
  • B N Mishra Department of Biotechnology, Institute of Engineering & Technology, Uttar Pradesh Technical University, Lucknow, India
  • Vivek Srivastava Department of Biotechnology, Institute of Engineering & Technology, Uttar Pradesh Technical University, Lucknow, India
  • Richa Chaudhary Department of Biotechnology, Institute of Engineering & Technology, Uttar Pradesh Technical University, Lucknow, India

DOI:

https://doi.org/10.37591/(rrjobi).v2i2.381

Abstract

Cryptosporidium parvum is an obligate, intracellular, protozoan parasite belonging to the phylum Apicomplexa. Cryptosporidium parvum is increasingly being recognized as an important pathogen causing diarrhea in children, with the highest associated morbidity and mortality, especially among children in developing countries. The highest prevalence of cryptosporidiosis has been documented in children aged 6–12 months. 3D QSAR studies were carried out on benzimidazole derivatives to identify new improved possible inhibitors. kNN-MFA methodology was used to conduct 3D QSAR studies which are to found to have better predictivity as compared to other regression methods. In this study, a good statistical model was generated on thirty two benzimidazole derivatives, which was used to design newer molecule with high binding affinity against IMPDH. These derivatives are active and can be used to generate 3D-QSAR model. A good statistical model developed by the stepwise kNN-MFA method having the cross validated correlation coefficient 68% (q2= 0.6852) and predictive correlation coefficient 93% (pred r2= 0.9325), showed the best prediction for IMPDH inhibition in test set of compounds. QSAR model indicate steric descriptor, at the grid points that play an important role to evaluate activity of new molecules. Thus, kNN-MFA stepwise contour plots and docking studies provide beneficial clues related to structural modification of substituted benzimidazole derivatives and their activities which should be applicable to design as well as predict activities of newly designed molecules. Further, to check the drug likeness of compounds, we also carried out ADME/Toxicity prediction.


Keywords: IMPDH, Benzimidazole, Cryptosporidium parvum, kNN-MFA

Cite this Article

Chandra Isha, Mishra BN, Srivastava   Vivek et al.  In- silico Design of Novel Inhibitors for Benzimidazole Receptor Against Cryptosporidium parvum. Research & Reviews: A Journal of Bioinformatics. 2015; 2(2): 1–10p.


Downloads

Published

2019-03-18

Issue

Vol. 2 No. 2 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.